Régulation immunitaire basée sur le ciblage de molécules d'activation précoce

• 收藏
• 分享

专利权人:

Albor Biologics; Inc.

发明人:

申请号：

EP11159912.2

公开号：

EP2347767A3

申请日:

2004.02.02

申请国别(地区):

EP

年份:

2013

代理人:

摘要：

Disclosed are methods of treating subjects having disorders or conditions characterized by an unwanted immune response including administering an effective amount of an early activation molecule agonist, antagonist or depletor, to the subject. Human monoclonal antibodies specific to the early activation molecules, and methods of use, are also disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/